Cargando…
Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men
BACKGROUND: Hormonal treatment of hypogonadism in thalassaemia major (TM) is a complex issue due to the co-existence of other contributing factors such as severity of iron overload, associated chronic liver disease and other endocrine complications. OBJECTIVES: Data about adverse events (AEs) of tes...
Autores principales: | Vincenzo, De Sanctis, Ashraf, T Soliman, Shahina, Daar, Salvatore, Di Maio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776204/ https://www.ncbi.nlm.nih.gov/pubmed/31125000 http://dx.doi.org/10.23750/abm.v90i2.8477 |
Ejemplares similares
-
Does Testosterone Replacement Therapy Promote an Augmented Risk of Thrombotic Events in Thalassemia Major Male Patients with Hypogonadism?
por: De Sanctis, Vincenzo, et al.
Publicado: (2017) -
Retrospective study on long-term effects of hormone replacement therapy (HRT) and iron chelation therapy on glucose homeostasis and insulin secretion in female ß- thalassemia major (β-TM) patients with acquired hypogonadotropic- hypogonadism (AHH)
por: De Sanctis, Vincenzo, et al.
Publicado: (2023) -
Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment
por: De Sanctis, Vincenzo, et al.
Publicado: (2018) -
Assessment of glucose homeostasis in young adult female β-thalassemia major patients (β-TM) with acquired hypogonadotropic hypogonadism (AHH) never treated with sex steroids compared to eugonadal β-TM patients with spontaneous menstrual cycles
por: de Sanctis, Vincenzo, et al.
Publicado: (2023) -
The experience of a tertiary unit on the clinical phenotype and management of hypogonadism in female adolescents and young adults with transfusion dependent thalassemia
por: Vincenzo, De Sanctis, et al.
Publicado: (2019)